New breast cancer gene raises risk in Europeans

	Tweet

Researchers have found another breast cancer gene that can greatly raise the risk of the disease in women of European heritage, according to a report published on Monday.

They said the gene worked in tandem with the well-known BRCA1 and BRCA2 genes to raise the risk of breast cancer by as much as 80 percent.

The team, at Iceland’s Decode Genetics, said their findings suggest women with certain mutations in two of the genes have an almost certain risk of breast cancer.

The new gene is called BARD1, Decode’s team reports in the online journal Public Library of Science Medicine.

“The BARD1 variant works together with the BRCA2 mutation in Iceland and increases the likelihood of breast cancer from 45 percent in those who have only the BRCA2 mutation up toward 100 percent in those who also have the BARD1 variant,” Decode chief executive Kari Stefansson said in a statement.

And women with the BARD1 variant who develop breast cancer are more likely to have tumors in both breasts, Stefansson said.

Breast cancer is known to run in families and has a genetic component, although most cases occur in people with no family history of the disease. Several genes are known to be involved, including the BRCA1 and BRCA2 genes, p53 and others.

The known BRCA1 and BRCA2 mutations only account for about 3 percent of all cases of the disease.

The Decode team is trying to find other genes that work with these genes.

They found 1,090 women in Iceland who had breast cancer, and compared them to 703 Icelandic women who did not. The company has a database carrying the genetic profiles of virtually everyone in Iceland.

A certain BARD1 mutation was found in 5.4 percent of breast cancer patients and 3.1 percent of women who did not have breast cancer—an 80 percent increase in risk, the researchers said.

Simply having the BARD1 mutation was not especially dangerous to a woman, but women who had it and a specific mutation on BRCA2 had a “dramatic” risk of breast cancer, the researchers found.

It may be worth developing a test for that particular combination, the researchers and the company said.

This BARD1 mutation has been found in Italian and Finnish families with a history of breast and ovarian cancer.

It has not been found in people of Chinese, Japanese, African-American and Yoruban descent, the researchers added.

“Therefore, the variant may be restricted to individuals with European ancestry and could contribute to the higher load of breast cancer seen in this group. However, other BARD1 variants have been discovered in African-American and Japanese individuals. The contribution of these variants to the risk of disease is still uncertain,” they wrote.

Breast cancer is the second leading cause of cancer deaths among women after lung cancer, affecting 1.2 million women globally and killing more than 400,000 every year, according to the International Agency for Research on Cancer.

RELATED STORIES:
Breast cancer vaccine helps body fight tumors   Yoga provides emotional benefits to women with breast cancer   Simple fingertip test may identify breast cancer patients at risk for carpal tunnel syndrome   Study helps eliminate causes for joint pain linked to commonly used breast cancer drugs   Shortening radiotherapy feasible for breast cancer   Obesity, estrogen breakdown tied to breast cancer   New model predicts relapse in early breast cancer patients following endocrine therapy   Study Finds Two Genes Predict Outcome for Breast Cancer Patients   Environmental pollutants and breast cancer   No Sure Answers to Reduce Mammography Discomfort   Breast Cancer Remains Threat for Older Women   HER-2 Status Predicts Success of Chemotherapy in Breast Cancer Treatment   Novel approach to treating breast cancer shows great promise   Racial disparities seen in male breast cancer survival   Early Stage, HER2 Positive Breast Cancer Patients at Increased Risk of Recurrence   New ‘seed’ therapy helps pinpoint breast tumors with more accuracy   Could therapeutic vaccines treat hard to beat breast cancers?   Ethnic breast cancer gap tied to mammography rates   Obese women increased the risk of breast cancer and larger the tumor size when detected   Blood thinners like aspirin may fight cancer: study   Consider the breast and lungs when determining thoracic imaging protocols   New Universal Breast Cancer Marker Predicts Recurrence and Clinical Outcome

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]